
**Utopia Theatre 1192008** 

## **Receipts and payments accounts** 

## **CC16a** 

**For the period** 01/07/2022 31/03/2023 **To from** 

## **Section A Receipts and payments** 

|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest      £**|**Unrestricted**<br>**funds**<br>**to the nearest      £**|**Restricted**<br>**funds**<br>**to the nearest £**|**Restricted**<br>**funds**<br>**to the nearest £**|**Endowment**<br>**funds**<br>**to the nearest £**|**Endowment**<br>**funds**<br>**to the nearest £**|**Total funds**<br>**to the nearest £**|**Total funds**<br>**to the nearest £**|**Last year**<br>**to the nearest £**|
|---|---|---|---|---|---|---|---|---|---|
|Just Giving|**-**||**-**||**-**||**-**||**87**|
|Donation|**-**||**-**||**-**||**-**||**-**|
|Grants receivable|**-**||**-**||**-**||**-**||**15,433**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
|**_Sub total_**_(Gross income for_<br>_AR)_|**-**||**-**||**-**||**-**||**15,520**|
|||||||||||
|**A2 Asset and investment sales,**<br>**(see table).**||||||||||
||**-**|||||||||
||**-**||||||||**-**|
|**_Sub total_**|**-**||||||||**-**|
|**_Total receipts_ **<br>**A3 Payments**||||||||||
||||||||||**15,520**|
|||||||||||
|Baobab|**-**||||||||**1,000**|
|Overheads|**-**||||||||**377**|
|Bank charges|**-**||||||||**-**|
|Consultancyfees|**-**||||||||**207**|
|Covid relief|**-**||||||||**1,795**|
|Anna Hibiscus R & D|**-**||||||||**1,708**|
||**-**||||||||**-**|
||**-**||||||||**-**|
||**-**||||||||**-**|
|**_Sub total_ **|**-**||||||||**5,087**|
|||||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**||||||||||
||**-**|||||||||
||**-**|||||||||
|**_Sub total_ **|**-**||||||||**-**|
|**_Total payments_ **<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**||||||||||
||||||||||**5,087**|
|||||||||||
||**-**||||||||**10,433**|
||**-**||||||||**-**|
||**10,442**||||||||**9**|
||**10,442**||||||||**10,442**|



CCXX R1 accounts (SS) 

17/01/2024 

1 



|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**||
|---|---|---|---|---|---|---|---|
|**Categories**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B5 Liabilities**<br>**B3 Investment assets**|Bank account<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>**Details**<br>**Details**||**Unrestricted**<br>**funds**<br>**to nearest £**<br>**10,442**<br>**-**<br>**-**<br>**10,442**<br>OK<br>**Unrestricted**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**||**Restricted**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>OK<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**||**Endowment**<br>**funds**<br>**to nearest £**|
||||||||**-**|
||||||||**-**|
||||||||**-**|
||||||||**-**|
||||||||OK|
||||||||**Endowment**<br>**funds**<br>**to nearest £**|
||||||||**-**|
||||||||**-**|
||||||||**-**|
||||||||**-**|
||||||||**-**|
||||||||**-**|
||||||||**Current value**<br>**(optional)**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||**Details**||**Fund to which**<br>**asset belongs**||**Cost (optional)**||**Current value**<br>**(optional)**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||**Details**||**Fund to which**<br>**liability relates**||**Amount due**<br>**(optional)**||**When due**<br>**(optional)**|
||||||**-**|||
||||||**-**|||
||||||**-**|||
||||||**-**|||
||||||**-**|||
||Signature||Print Name<br>Maxine Greaves|||||
||||||||Date of<br>approval|
||||Maxine Greaves||||15/01/2024|
|||||||||



CCXX R2 accounts (SS) 

17/01/2024 

2 

